Now is a golden opportunity to change primary care
The next few months might be an inflection point for GPs in England and Wales Our strong primary care system is often credited in the succes...
Radio and PodcastLive Radio & PodcastsScience & Medicine
The BMJ Podcast
The BMJ is an international peer reviewed medical journal and a fully “online first” publication. The BMJ’s vision is to be the world’s most influential and widely read medical journal. Our...
Episodes
20 of 1,063 episodesWhen medical exams go wrong, & CTE in the NFL
In this week’s podcast we’ll be hearing a lot about exams - the bane of many doctor’s training lives, exams that determine your future are s...
AI in healthcare - getting it right, and stopping it going wrong
This week we’re focusing on how healthcare is using AI systems. The NHS is firmly set on a course of AI integration, with NHS England commit...
New analysis on Bipolar treatment, and vaccines for malaria
Bipolar disorder affects almost 40 million people worldwide, but finding the right treatment is complex, and nearly half of patients struggl...
We need to understand how global market forces undermine healthcare
This week we focus on the external forces that shape medicine and healthcare. Global health is changing, after the reduction in financing fr...
Are doctors afraid of death?
In this week's podcast - the Sensitivity of Patient Questionnaires: If you've ever asked a patient to fill out a Patient Health Questionnair...
Is Burnham's 'Manchesterism' the fix for health & social care?
Known for his use of devolved powers, during his tenure as Mayor of Greater Manchester, Andy Burnham now has the opportunity to bring his lo...
Measuring ethnicity in research, NHS job discrimination, and how medicine led evidence revolution
Discrimination in NHS Hiring: We examine the troubling success rates of Black and Asian doctors when applying for NHS jobs. Deputy news edit...
Hands off our data: the need for sovereignty in a connected world
Who actually owns our health data once it is stored in the cloud? And how do we balance the global push for open medical research with the n...
750 recommendations, and little change - why the UK keeps having maternity care reviews.
Two NHS maternity reviews have been published over the past few weeks. The biggest ever conducted, involving nearly 2500 families, investiga...
Children are bypassing the Australian social media ban
Australia has been in the vanguard of legislation to try and reduce the influence of social media on children and young people - their ban f...
The £400 million blackhole for doctor training, drug ads evading regulation, and reining in AI in war
The US military’s Operation “Epic Fury” highlighted the devastating cost of using artificial intelligence for rapid military planning. Thoma...
Cancer screening: when does testing go too far?
The heated debate on prostate cancer screening boils down to one question: should men be routinely screened? Two recent position statements...
Child mortality has reduced, but there are worrying trends
New estimates of Global Patterns in Neonatal, Child, and Adolescent Mortality have been published - and while there has been a huge improvem...
How to make healthcare more human
Does healthcare have a moral emergency? In this episode of the Medicine and Science podcast, Kamran Abbasi sits down with healthcare leaders...
What does Wes Streeting's exit mean for the NHS modernisation bill?
It has been a tumultuous time in UK health politics. UK Health Minister ,Wes Streeting, has freshly resigned. What does this mean for his ne...
Social media companies are using the tobacco industry playbook to addict children
Twitter was launched 20 years ago, followed quickly by the iPhone and Instagram. Today, nearly 60% of the world’s population uses social med...
Revisiting the Cass Review on gender identity services, and non-invasive brain stimulation for children with autism
The BMA has released their long awaited review of the Cass report. The original report looked at the provision of NHS gender identity servic...
The US UK trade deal will cost the NHS billions, and only serve to increase pharma profits
The new trade deal struck between the UK and US came into force in April. The deal will double the amount that the NHS spends on new medicin...
MS drug controversy, adoption outcomes in Sweden, and the multi-factorial reality of Alzheimer’s
A blockbuster MS drug undergoes FDA re-evaluation. We explore the story of Ocrelizumab, a treatment for primary progressive multiple scleros...